Author Archive
Diet Drug Acomplia Sales Disappoint; No Major Improvement Seen Until 2009
Sales of diet drug Acomplia (rimonabant) , available in Europe but not approved in the U.S., have turned into a major disappointment for Sanofi-Aventis, which says it does not expect the situation to significantly improve until new clinical trial results are ready for submission to regulators in [...]
Sanofi to Present More Acomplia Data at April 11th Meeting
Sanofi-Aventis, developer of the highly publicized anti–obesity drug Acomplia, will present new data on the drug’s role in reducing metabolic cardiovascular disease risk factors at a scientific meeting in San Diego April 11th and 12th.
Dr. Pierre Rosenzweig, a Vice President of Sanofi-Aventis, will make the presentation at the Annual Metabolic [...]
Report in The Lancet Further Boosts Interest in Weight-Loss Drug Acomplia
A report published in this week’s issue of the prestigious medical journal, The Lancet, further stoked interest in the promising new weight-loss drug Acomplia (rimonabant) but in fact provided little new information.
The report was based on one-year results from the RIO–Europe clinical trial, which [...]
Support for “Metabolic Syndrome” May Buttress Expanded Role for Acomplia
The American Heart Association (AHA) and the National Heart, Lung and Blood Institute (NHLBI) on Sept. 13 issued a new scientific statement taking issue with two major diabetes organizations Acomplia (rimonabant) that a month ago questioned the validity of diagnosing patients with “metabolic syndrome.”
The debate could well impact efforts of [...]
FDA Advisory Panel Says Obese Kids Should Be Included in Drug Trials
A U.S. FDA Advisory Committee reviewing guidelines for weight-loss drug trials appear prepared to call for studies that focus on the effect of anti–obesity drugs on severely obese children Acomplia (rimonabant) .
Acomplia (rimonabant) “This population of patients needs to be studied separately from the [...]
Diet Pill Acomplia Now Widely Available in Mexican Border Pharmacies
Diet drug Acomplia (rimonabant) , which seems at best months away from sale in the United States, is now widely available in pharmacies just across the Mexican border.
Readers increasingly are sending us reports on their experiences purchasing the highly anticipated diet pill in Mexican towns just across [...]
Q .Which Credit/Debit cards do you accept?
At present we accept the following cards: Visa, Visa Electron, Maestro, Mastercard, Switch and Solo.
Experimental Obesity Drug APD356 Reported Effective in Small, Short Trial
A year ago at this time, millions of overweight and obese An experimental drug for the treatment of obesity, APD356, reportedly produced encouraging results in a relatively small four week clinical trial, according to a statement released by Arena Pharmaceuticals, Inc Acomplia (rimonabant) .
Arena said [...]
